《European Neuropsychopharmacology》雜志的最新年發文量為83篇。
這表明該刊在每年都會精選并發表一定數量的高質量文章，以保持其在臨床神經病學領域的學術影響力。
該刊聚焦于醫學-臨床神經病學領域的前沿研究，致力于推動該領域新技術和新知識的傳播與應用。同時它積極鼓勵研究人員詳細發表其高質量的實驗研究和理論成果。
該刊的平均審稿周期約為 偏慢,4-8周 。
European Neuropsychopharmacology 雜志發文統計
文章名稱引用次數
- Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan70
- Manifesto for a European research network into Problematic Usage of the Internet33
- Increased cortical neuronal responses to NMDA and improved attentional set-shifting performance in rats following prebiotic (B-GOS (R)) ingestion17
- Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies16
- Nutritional psychiatry: Towards improving mental health by what you eat14
- Early intervention for obsessive compulsive disorder: An expert consensus statement14
- Activation of the immune-inflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis12
- Discrepancy between objective and subjective cognition in major depressive disorder12
- Chronic treatment with URB597 ameliorates post-stress symptoms in a rat model of PTSD12
- Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis12
國家/地區發文量
- USA1203
- England630
- GERMANY (FED REP GER)530
- Spain514
- Netherlands402
- Italy369
- Canada275
- Russia271
- Denmark222
- Australia205
